
Addus HomeCare (ADUS) Stock Forecast & Price Target
Addus HomeCare (ADUS) Analyst Ratings
Bulls say
Addus HomeCare has demonstrated robust organic revenue growth in its personal care segment, reporting an impressive 12.3% year-over-year increase in 2023, with continued growth projected at 7.7% for 2024 and 7.4% year-to-date in 2025. The recently finalized Medicare hospice rate increase of 2.6% is anticipated to bolster revenue for the Hospice segment, which is expected to achieve steady growth rates of 5% to 7% facilitated by operational improvements and potential mergers and acquisitions. Given these positive financial trends and the ongoing demand for in-home care services, Addus HomeCare presents a favorable outlook for future growth.
Bears say
Addus HomeCare's financial outlook is negatively impacted by ongoing declines in same-store revenues, primarily due to Medicaid redeterminations causing administrative delays that hinder patient onboarding and result in higher discharge rates than admissions. Additionally, approximately 97% of the company's segment revenues are tied to Medicaid, creating significant uncertainty regarding future funding as a result of the One Big Beautiful Bill Act (OBBBA). Despite strong execution and a business model poised for long-term demand, the disconnect between equity valuation and fundamental performance raises concerns about the company's relative viability in the post-acute care market.
This aggregate rating is based on analysts' research of Addus HomeCare and is not a guaranteed prediction by Public.com or investment advice.
Addus HomeCare (ADUS) Analyst Forecast & Price Prediction
Start investing in Addus HomeCare (ADUS)
Order type
Buy in
Order amount
Est. shares
0 shares